induced pluripotent stem (iPS) cells

Kyoto University Hospital prepares clinical trials for Type 1 Diabetes treatment

Type 1 diabetes is a chronic illness characterized by the body's inability to produce insulin due to the autoimmune destruction of pancreatic beta cells.